Biologics Market Definition
Biologics refer to a class of pharmaceutical products derived from living organisms or their components. Unlike chemically synthesized drugs, biologics include large, structurally intricate molecules such as monoclonal antibodies, therapeutic proteins, and vaccines. These products are primarily used in the treatment, prevention, or diagnosis of serious and chronic conditions such as cancer, autoimmune disorders, metabolic diseases, and infectious diseases. They are indispensable in modern medicine for their targeted action, high efficacy, and ability to treat previously untreatable conditions.
The biologics market consists of sales, by entities such as organizations, sole traders, and partnerships, of therapeutic products that are used in diverse medical settings, ranging from acute care hospitals and specialty clinics to community health centers and outpatient treatment facilities. They often complement other forms of therapy, such as conventional pharmaceuticals, surgery, or radiation therapy, and can sometimes replace older treatment regimens where higher efficacy or fewer side effects are desired.
